Premarket Stock Movers — August 27, 2026: Why PPCB, VNRX, MERC, WNW & YAAS Are Surging

PPCB — Propanc Biopharma, Inc. (+251.8%)

Propanc Biopharma is surging +251.8% to $3.87 in premarket trading on a staggering 24.6 million shares — versus its quiet 20-day average of just 134,356. That's roughly 183× its normal daily volume before the opening bell has even rung. For a micro-cap biotech with a $62.7M market cap, that kind of premarket flow is almost never routine.

Why it's moving: No researched catalyst is on file, and there are no earnings releases or material headlines tied to this move. The only recent SEC activity is a DEF 14C (an informational proxy filing, considered neutral) filed on August 21. With no identifiable fundamental driver, this looks like a momentum- and technically-driven spike, possibly amplified by social-media or retail-trader activity targeting a thinly traded name.

On the short-squeeze angle — a short squeeze occurs when traders who bet against a stock are forced to buy shares to cover their positions, pushing the price higher — the picture here is modest. PPCB's squeeze score is just 21/100, short interest is tiny at 20,152 shares, and days to cover (the time it would take short sellers to exit at average volume) is a mere 0.2 days. This is not a classical squeeze setup. The short-volume reading of 88% is worth noting, though that metric reflects intraday short-side activity and does not directly indicate short interest.

Heading into today, the StockSetups daily chart through yesterday's close showed a mixed moving-average stack, RSI of 42 (neutral territory), and an ADX of 21 (indicating a weak trend). The conviction score is just 27/100 with a grade of D, and the stock sits 64.7% below its 52-week high. This is a high-risk, low-conviction technical name: the premarket surge is extreme relative to the underlying setup, and violent reversals in names like this are common once regular-hours liquidity arrives.

VNRX — VolitionRx Ltd (+90.8%)

VolitionRx is trading +90.8% to $0.64 premarket on a massive 194.8 million shares — 125× its 20-day average volume of 1.56 million. At a market cap of just $4.6M, this is an extremely small and volatile stock, and the premarket move reflects a genuine news catalyst.

Why it's moving: Two major press releases hit the wires on August 26. First, VolitionRx announced landmark clinical validation of its Nu.Q® NETs biomarker in sepsis — a potentially significant milestone for a diagnostic-focused biotech. Nu.Q is the company's proprietary nucleosome-based testing platform, and validation in a serious condition like sepsis can signal a meaningful step toward commercial adoption. Simultaneously, the company highlighted commercial momentum across $27+ billion in total addressable markets, framing multiple business pillars as on track. That combination of clinical and commercial newsflow in a single day is a powerful short-term catalyst for a micro-cap name.

Traders should be aware of the dilution overhang: an 8-K filed August 24 discloses an unregistered equity sale (a bearish signal, as it can increase share count and dilute existing holders), and a prior 8-K on August 7 flagged another dilution event. A Short Sale Restriction (SSR) is active, meaning regulators have limited certain short-selling activity after the stock's prior-session decline — this can reduce downward pressure but doesn't guarantee upside continuation. The squeeze score is 34/100, with 1.8 days to cover and 538,529 shares short.

The prior-day setup on StockSetups showed an RSI of 16 — deeply oversold — alongside an ADX of 44 (strong trend, though bearish in direction), a mixed MA stack, and the stock 89.3% below its 52-week high. The conviction score of 47/100 (grade C) and RS rating of 98 paint a picture of a stock with relative-strength momentum but a technically beaten-down chart. A largest disclosed stake of 14.0% suggests at least one significant holder is on record. The news catalyst is real; whether premarket gains hold into the regular session for a stock this small and this dilution-prone is genuinely uncertain.

MERC — Mercer International Inc. (+71.3%)

Mercer International is surging +71.3% to $0.69 on 45.4 million premarket shares — compared to a 20-day average of 442,751, that's more than 102× normal volume. The company operates pulp mills and is classified in the Materials sector, with a current market cap of $26.9M.

Why it's moving: The catalyst is clear and sourced from multiple outlets. On August 26, Mercer International announced it has received C$20 million (approximately US$14 million) in Government of Canada support for its Peace River Mill in Alberta. According to coverage from Stock Titan and Yahoo Finance, the federal funding is tied to preparations for carbon capture and storage (CCS) — positioning the mill for innovation and enhanced competitiveness in Northern Alberta's forest sector. A Benzinga headline describes the stock as soaring 84% after-hours on this news. Government grants of this size relative to a sub-$30M market cap represent a material injection of non-dilutive capital, which helps explain the outsized market reaction.

From a short-squeeze perspective (forced buying by short sellers when a stock rises sharply), MERC has more meaningful short exposure than the other movers today: a squeeze score of 56/100, 8.3 days to cover, and 3.21 million shares short with a 61% short-volume reading. That combination means short sellers may be contributing to the buying pressure this morning. A smart-money score of 22/100 and a largest disclosed stake of 40.3% indicate significant concentrated ownership — a large holder that doesn't exit into this move can help support the price, but concentration also raises liquidity risk.

The prior-day chart carried a decidedly weak technical setup: bearish MA stack, RSI of 31, ADX of 31, a conviction score of 0/100 (grade D), trend-template score of 0, and the stock sitting 87.9% below its 52-week high. An RS rating of just 1 confirms this was one of the weakest relative-strength stocks in the entire market before this morning. Insider Peter R. Kellogg made a series of open-market purchases totaling over $194K in share value between June 10–12 — a potentially meaningful show of insider confidence at lower prices, though those purchases precede today's catalyst. The technical picture was broken heading in; the government funding news is doing the heavy lifting here.

WNW — Meiwu Technology Co Ltd (+32.8%)

Meiwu Technology is up +32.8% to $3.28 premarket on 7.39 million shares — nearly 97× its 20-day average volume of 75,938. The Chinese e-commerce company carries a $38.6M market cap and sits in the Consumer Discretionary sector.

Why it's moving: The only recent filing on record is a 6-K filed August 26 (a form used by foreign private issuers to report material events), labeled as a foreign corporate event. No detailed headline or press release is available to clarify what the 6-K disclosed. Given the absence of a researched catalyst, this move appears to be momentum- and technically-driven, with the filing potentially acting as a trigger for retail traders watching for any activity in a thinly traded name.

The short profile provides limited squeeze fuel: a squeeze score of 22/100, just 29,638 shares short, and a 0.2 days-to-cover figure mean there's not a significant short position being forced to cover. However, short-volume is 80% — a notably high proportion of trading activity coming from the short side in prior sessions. The free float of 52.4% (meaning just over half the shares are freely tradeable) means relatively thin supply of shares, which can amplify price moves in both directions on heavy volume.

The prior-day StockSetups chart showed a mixed MA stack, RSI of 41, ADX of 18 (a weak, non-trending environment), and the stock 57.9% below its 52-week high. Conviction is 27/100 (grade D), and the trend-template score of 4 suggests the stock doesn't yet meet the criteria of a strong, sustained uptrend. An HRT Financial LP Form 4 buy of 3,069 shares ($11K) was filed back in May — institutional scale, but a modest position. Without a clear catalyst on record, this premarket move deserves extra caution.

YAAS — Youxin Technology Ltd (+25.5%)

Youxin Technology is trading +25.5% to $3.25 premarket on 24.2 million shares — 169× its 20-day average volume of 143,518. This micro-cap technology company has a market cap of just $6.0M, making it the smallest name on today's list.

Why it's moving: No catalyst, headline, or SEC filing has been identified for this morning's move. With no news on record, the surge appears to be momentum-driven, potentially fueled by retail activity in a very low-float, low-market-cap name that can move sharply on relatively small dollar volume.

Interestingly, YAAS has the strongest technical setup of today's five movers heading into this premarket spike. The prior-day chart showed a bullish MA stack, RSI of 59 (healthy momentum without being overbought), ADX of 63 (a strong and trending market), and the stock just 17.8% below its 52-week high — far closer to its highs than any other name on this list. The conviction score is 67/100 with a grade of B, and the trend-template score is 5 (the maximum), meaning YAAS met all the conditions of the Minervini trend template — strong price above rising moving averages — heading into today. The technical rank of 92 and RS rating of 97 reinforce that StockSetups identified this as a technically leading stock before the premarket move.

The short profile is minimal: squeeze score of 17/100, 110,589 shares short, and 0.6 days to cover — this is not a squeeze story. A three outside down candlestick pattern was flagged on the prior-day chart (a bearish reversal candle signal), which is worth noting even amid the bullish trend backdrop. The volume expansion this morning is dramatic, but with no known catalyst, the sustainability of a +25% premarket move in a $6M market cap stock is highly unpredictable.

The bottom line

This morning's premarket leaderboard spans a biotech mystery spike (PPCB), a diagnostic-company news pop (VNRX), a government-grant winner (MERC), a foreign-event filing mover (WNW), and a technically strong but catalyst-free momentum runner (YAAS). As a group, they illustrate how varied the drivers of premarket volatility can be — from genuine fundamental catalysts to pure price momentum in thinly traded names.

A few honest reminders before the open:

• Premarket prices are not regular-session prices. Volume is far lighter before 9:30 AM ET, spreads are wider, and large premarket gains frequently compress — or reverse entirely — once the full market opens and profit-takers arrive.
• The biggest gainers are often the highest-risk names. Several of today's movers are micro-caps trading well below their 52-week highs, with weak conviction scores and no identifiable catalyst. Chasing extended premarket moves without a plan is one of the fastest ways to lose capital.
• Dilution is a live risk. VNRX has filed multiple dilution-related 8-Ks in recent weeks. For any small-cap biotech, new share issuance can offset price gains quickly.
• Short squeezes and momentum can reverse without warning. MERC has meaningful short interest that may be adding buying pressure — but once short sellers have covered, that bid can evaporate.

Always define your risk before entering any trade, size positions appropriately, and do your own research beyond what a morning recap can provide. Nothing here is financial advice or a recommendation to buy or sell any security.

StockSetups scans the full ~12,300-stock US universe every premarket morning, detecting chart patterns, candlestick signals, squeeze setups, and smart-money activity — so you can see which names are technically positioned before the open bell rings. For yesterday's after-close action, see Top Stock Movers Today — August 26, 2026 or this time yesterday's Premarket Stock Movers — August 26, 2026.